Clinical Trial Update: Long Term Beta Thalassemia Treatment: Findings From The Extension Period [Phase 2]

View source ↗

Summary

Long-term extension-period findings from a Phase 2 trial evaluating treatment for beta-thalassemia are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Snippet

Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | Conditions: Fetal Hemoglobin, Beta-Thalassemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING